"Osceola Regional Medical Center is now HCA Florida Osceola Hospital. We are a 404-bed tertiary care hospital accredited by The Joint Commission and are designated as a Level II Trauma Center. We are also a teaching hospital in collaboration with UCF College of Medicine. The hospital campus is centrally located in the heart of Kissimmee, accessible from Orlando, St. Cloud, Celebration and Poinciana. Our specialties include full-scale adult and pediatric emergency care, womens health services, behavioral health care and orthopedics and spine care. We are home to the Heart and Vascular Institute, Baby Suites maternity care, and a Level II Neonatal Intensive Care Unit (NICU). Visit our website to find out more about our hospital and services."

During the past decade, Osceola Regional Medical Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 7 clinical trials were completed, i.e. on average, 116.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Osceola Regional Medical Center" #1 sponsor was "Harvard Pilgrim Health Care" with 3 trials, followed by "3M" with 1 trials sponsored, "Biosense Webster, Inc." with 1 trials sponsored, "Biotronik, Inc." with 1 trials sponsored and "Boston Scientific Corporation" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Osceola Regional Medical Center" #1 collaborator was "Centers for Disease Control and Prevention" with 4 trials as a collaborator, "University of California, Irvine" with 3 trials as a collaborator, "University of Massachusetts, Amherst" with 3 trials as a collaborator, "Brigham and Women's Hospital" with 2 trials as a collaborator and "Hospital Corporation of America Healthcare (HCA)" with 2 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Osceola Regional Medical Center" are "Acute Coronary Syndromes" (1 trials), "Atrial Fibrillation" (1 trials), "Cardiac Implantable Electronic Device Infection" (1 trials), "Contrast Induced Kidney Injury." (1 trials) and "Flail Chest" (1 trials). Many other conditions were trialed in "Osceola Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Osceola Regional Medical Center" are "Device" (4 trials), "Drug" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "INSPIRE CPOE Smart Prompt" (2 trials), "Routine Care" (2 trials), "Arm 1. Routine Care (Mupirocin/CHG)" (1 trials), "Arm 2. Iodophor/CHG Decolonization" (1 trials) and "Arm 2: Decolonization" (1 trials). Other intervention names were less common.

The vast majority of trials in "Osceola Regional Medical Center" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Osceola Regional Medical Center". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Osceola Regional Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Osceola Regional Medical Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".